Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 133 Records) |
| Query Trace: Disease and DRD2[original query] |
|---|
| BDNF, COMT, and DRD2 polymorphisms and ability to return to work in adult patients with low- and high-grade glioma. Neuro-oncology practice 2019 9 6 (5): 375-385. Altshuler David B, Wang Lin, Zhao Lili, Miklja Zachary, Linzey Joey, Brezzell Amanda, Kakaizada Sofia, Krishna Saritha, Orringer Daniel A, Briceño Emily M, Gabel Nicolette, Hervey-Jumper Shawn |
| Association between the DRD2 TaqIA gene polymorphism and Parkinson disease risk: an updated meta-analysis. Medicine 2019 Sep 98 (37): e17136. Yu Ming, Huang Feiran, Wang Wei, Zhao Ch |
| Association between dopamine receptor D2 Taq IA gene polymorphism and persistent postural-perceptual dizziness. Journal of vestibular research : equilibrium & orientation 2019 29 (2-3): 131-136. Cui Liping, Yan Zhihui, Gong Lifeng, Tang Jianhua, Kong Min, Sun Fengnan, Yu Quntao, Liang Hui, Chen Chun |
| Effects of a GWAS-Supported Schizophrenia Variant in the DRD2 Locus on Disease Risk, Anhedonia, and Prefrontal Cortical Thickness. Journal of molecular neuroscience : MN 2019 May . Alfimova Margarita V, Kondratyev Nikolay V, Tomyshev Alexander S, Lebedeva Irina S, Lezheiko Tatyana V, Kaleda Vasiliy G, Abramova Lilia I, Golimbet Vera |
| Clinical and Clinical-Pharmacogenetic Models for Prediction of the Most Common Psychiatric Complications Due to Dopaminergic Treatment in Parkinson's Disease. The international journal of neuropsychopharmacology 2020 7 23 (8): 496-504. Redenšek Sara, Jenko Bizjan Barbara, Trošt Maja, Dolžan Vi |
| In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing. Current psychopharmacology 2020 5 9 (1): 7-21. Blum Kenneth, Baron David, Lott Lisa, Ponce Jessica V, Siwicki David, Boyett Brent, Steinberg Bruce, Modestino Edward J, Fried Lyle, Hauser Mary, Simpatico Thomas, Downs Bill W, McLaughlin Thomas, Hajela Raju, Badgaiyan Rajendra |
| Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia. Archives of medical research 2020 Feb 51 (1): 13-20. Zakharyan Roksana, Ghazaryan Hovsep, Kocourkova Lenka, Chavushyan Andranik, Mkrtchyan Artur, Zizkova Veronika, Arakelyan Arsen, Petrek Mart |
| Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy. Genetic testing and molecular biomarkers 2020 Dec . Zhang Rongbo, Li Jing, Wu You, Liang Shunli, Xu Linshe |
| Facial Emotion Recognition and Polymorphisms of Dopaminergic Pathway Genes in Children with ASD. Behavioural neurology 2020 2020 6376842. Liu Zhuo, Liu Jun, Zhang Zengyu, Yu Hong, Hu Fengp |
| Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease. Clinical neurology and neurosurgery 2020 Oct 199 106257. Eryilmaz Isil Ezgi, Erer Sevda, Zarifoglu Mehmet, Egeli Unal, Karakus Ece, Yurdacan Beste, Cecener Gulsah, Tunca Berrin, Colakoglu Beril, Bora Tokcaer Ayse, Saka Esen, Demirkiran Meltem, Akbostanci Cenk, Dogu Okan, Kaleagasi Hakan, Kenangil Gulay, Cakmur Raif, Elibol Bule |
Functional validity, role, and implications of heavy alcohol consumption genetic loci.
Science advances 2020 01 6 (3): eaay5034. Thompson Andrew, Cook James, Choquet Hélène, Jorgenson Eric, Yin Jie, Kinnunen Tarja, Barclay Jeff, Morris Andrew P, Pirmohamed Mun |
| Association between dopamine receptor D2 TaqIA polymorphism and Parkinson disease risk: a meta-analysis. International journal of clinical and experimental pathology 2019 12 (9): 3165-3170. Song Yang, Wang Zhi-Yun, Jin Yan-Yu, Guo J |
| Treatment Response and GWAS Risk Allele rs2514218 (C) of the Dopamine D2 Receptor Gene in Inpatients with Schizophrenia. Neuropsychobiology 2021 Sep 1-7. Morozova Margarita A, Lezheiko Tatyana V, Lepilkina Taissia A, Burminskiy Denis S, Potanin Sergey S, Beniashvili Allan G, Rupchev George E, Golimbet Vera |
| Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Medicinal research reviews 2021 6 41 (5): 2841-2886. Cacabelos Ramón, Carrera Iván, Martínez Olaia, Alejo Ramón, Fernández-Novoa Lucía, Cacabelos Pablo, Corzo Lola, Rodríguez Susana, Alcaraz Margarita, Nebril Laura, Tellado Iván, Cacabelos Natalia, Pego Rocío, Naidoo Vinogran, Carril Juan |
| Clinical and Genetic Analysis of Psychosis in Parkinson's Disease. Journal of Parkinson's disease 2021 Jun . Radojevi? Branislava, Dragaševi?-Miškovi? Nataša T, Marjanovi? Ana, Brankovi? Marija, Dobri?i? Valerija, Milovanovi? Andona, Tomi? Aleksandra, Svetel Marina, Petrovi? Igor, Jan?i? Ivan, Stanisavljevi? Dejana, Savi? Miroslav M, Kosti? Vladimir |
| Genetic underpinnings of sociability in the general population.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2021 May . Bralten Janita, Mota Nina R, Klemann Cornelius J H M, De Witte Ward, Laing Emma, Collier David A, de Kluiver Hilde, Bauduin Stephanie E E C, Arango Celso, Ayuso-Mateos Jose L, Fabbri Chiara, Kas Martien J, van der Wee Nic, Penninx Brenda W J H, Serretti Alessandro, Franke Barbara, Poelmans Gee |
| Association between autism spectrum disorder and polymorphisms in genes encoding serotine and dopamine receptors. Metabolic brain disease 2021 Mar . Liu Jun, Fu Huamei, Kong Jiangying, Yu Hong, Zhang Zeng |
| Genetic Markers as Risk Factors for the Development of Impulsive-Compulsive Behaviors in Patients with Parkinson's Disease Receiving Dopaminergic Therapy. Journal of personalized medicine 2021 12 11 (12): . Fedosova Anna, Titova Nataliya, Kokaeva Zarema, Shipilova Natalia, Katunina Elena, Klimov Euge |
| Polymorphism of neurodegeneration-related genes associated with Parkinson's disease risk. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022 6 43 (9): 5301-5312. Li Jiaxin, Yi Minhan, Li Binbin, Yin Shujuan, Zhang Ying, Huang Zini, Shu Li, Zhang Yu |
| DRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson's Disease: Voxel-Based Morphometry. Parkinson's disease 2022 4 2022 8649195. Ohira Kenji, Yokota Hajime, Hirano Shigeki, Nishimura Motoi, Mukai Hiroki, Horikoshi Takuro, Sawai Setsu, Yamanaka Yoshitaka, Yamamoto Tatsuya, Kakeda Shingo, Kuwabara Satoshi, Tanaka Tomoaki, Uno Takas |
| Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population. Frontiers in nutrition 2022 4 9 838177. Ceccarini Maria Rachele, Fittipaldi Simona, Ciccacci Cinzia, Granese Erika, Centofanti Federica, Dalla Ragione Laura, Bertelli Matteo, Beccari Tommaso, Botta Annali |
| Clustering of Parkinson subtypes reveals strong influence of DRD2 polymorphism and gender. Scientific reports 2022 4 12 (1): 6038. Pelzer Esther Annegret, Stürmer Sophie, Feis Delia-Lisa, Melzer Corina, Schwartz Frank, Scharge Marcel, Eggers Carsten, Tittgemeyer Marc, Timmermann La |
| The correlation between genetic factors and freezing of gait in patients with Parkinson's disease. Parkinsonism & related disorders 2022 4 98 7-12. Radojevi? Branislava, Dragaševi?-Miškovi? Nataša T, Marjanovi? Ana, Brankovi? Marija, Milovanovi? Andona, Petrovi? Igor, Svetel Marina, Jan?i? Ivan, Stanisavljevi? Dejana, Mili?evi? Ognjen, Savi? Miroslav M, Kosti? Vladimir |
| Study of changes in rs2283265 polymorphisms in dopamine receptor D2 and rs27072 in dopamine transporter gene (SLC6A3) in patients with attention-deficit hyperactivity disorder. Iranian journal of child neurology 2022 16 (3): 121-132. Safavi Parvin, Soleimani Farsani Hossein, Farrokhi Effat, Malekpour Tehrani Afsaneh, Khoshdel Nika, Khoshdel Abolfa |
| Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022 Jan . Soraya Gita Vita, Ulhaq Zulvikar Syambani, Shodry Syifaus, A'raaf Sirojan Kusuma Muhammad, Herawangsa Sarah, Sativa Maharani Oryza, Gustaf Aridin, Faridwazdi Dzakky Avecienna Nur, Florentia Shinta Wulandari, Raisa Neila, Bintang Andi Kurnia, Akbar Muhamm |
| The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson's Disease. Journal of molecular neuroscience : MN 2022 Jan . Zapa?a Barbara, Stefura Tomasz, Piwowar Monika, Czekalska Sylwia, Zawada Magdalena, Hadasik Maria, Solnica Bogdan, Rudzi?ska-Bar Moni |
| No association of the dopamine D2 receptor genetic bilocus score (rs1800497/rs1799732) on food addiction and food reinforcement in Chilean adults. Frontiers in behavioral neuroscience 2023 4 17 1067384. Hidalgo Vira Nicole, Oyarce Karina, Valladares Vega Macarena, Goldfield Gary S, Guzmán-Gutiérrez Enrique, Obregón Ana |
| Associations between variants in levodopa metabolic pathway genes and levodopa-induced dyskinesia in Parkinson's disease. Neuroscience letters 2023 2 801 137140. Yan Jia-Hui, Ge Yi-Lun, Wang Pu-Zhi, Li Wen, Jin Hong, Zhang Jin-Ru, Chen Jing, Wang Fen, Li Dan, Mao Cheng-Jie, Li Kai, Liu Chun-Fe |
| CHRNA5-A3-B4, CYP2A6, and DBH genetic associations with smoking cessation throughout adulthood within two longitudinal studies of women. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2024 12 . Stephanie K Jones, Anthony J Alberg, Kristin Wallace, Brett Froeliger, Matthew J Carpenter, Bethany J Wo |
| Different risk and protective factors predict change of planning ability in middle versus older age. Scientific reports 2024 10 14 (1): 25275. Josef M Unterrainer, Julia Petersen, Peter Schmidt, Mareike Ernst, Markus A Wirtz, Anna C Reinwarth, Felix Wicke, Jasmin Ghaemi Kerahrodi, Matthias Michal, Thomas Münzel, Jochem König, Karl J Lackner, Norbert Pfeiffer, Oliver Tüscher, Peter R Galle, Manfred Beutel, Philipp S Wi |
- Page last reviewed:Feb 1, 2024
- Content source: